Clincosm LogoSign in Get a demo

myelofibrosis

Showing NaN - NaN of 25
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +10 more
  • Jacksonville, Florida
  • +5 more
Aug 14, 2023

Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

Active, not recruiting
  • Myelofibrosis
  • Chronic Myelomonocytic Leukemia
  • Duarte, California
  • +9 more
Jan 24, 2023

Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

Recruiting
  • Myelofibrosis
  • +3 more
  • Berkeley, California
  • +176 more
Dec 1, 2022

Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

Recruiting
  • Myelofibrosis
  • +3 more
  • Anchorage, Alaska
  • +172 more
Dec 1, 2022

Myelofibrosis Trial in United States (Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Boston, Massachusetts
  • +4 more
Oct 21, 2022

Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Worldwide (Pelabresib, Ruxolitinib, Placebo)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +148 more
Oct 10, 2022

Myelofibrosis Trial in United States (Ruxolitinib, Thalidomide)

Active, not recruiting
  • Myelofibrosis
  • Middletown, New Jersey
  • +6 more
Aug 23, 2022

Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)

Recruiting
  • Myeloproliferative Disorders
  • +4 more
  • La Jolla, California
  • +184 more
Aug 22, 2022

Myelofibrosis Trial in Worldwide (Imetelstat, Best Available Therapy (BAT))

Recruiting
  • Myelofibrosis
  • La Jolla, California
  • +165 more
Aug 19, 2022

Myelofibrosis Trial in Coral Gables, Tampa, New York (Imetelstat, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Coral Gables, Florida
  • +2 more
Jul 12, 2022

Myelofibrosis, Essential Thrombocythemia, MPN Trial in New York (Peptide-based vaccine, Poly ICLC)

Not yet recruiting
  • Myelofibrosis
  • +2 more
  • Peptide-based vaccine
  • Poly ICLC
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jun 7, 2022

Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis Trial in Worldwide (KRT-232, TL-895)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +36 more
May 5, 2022

Myelofibrosis Trial in Worldwide (Imetelstat 4.7 mg/kg, Imetelstat 9.4 mg/kg)

Completed
Has Results
  • Myelofibrosis
  • Imetelstat 4.7 mg/kg
  • Imetelstat 9.4 mg/kg
  • Birmingham, Alabama
  • +71 more
Aug 17, 2021

Cancer, Metastatic, Cancer, Cancer of Pancreas Trial in New York (Clinical Trial Matching)

Recruiting
  • Cancer, Metastatic
  • +42 more
  • Clinical Trial Matching
  • New York, New York
    Massive Bio, Inc
May 21, 2021

Myelofibrosis With Myeloid Metaplasia, Myeloid Metaplasia, Myelofibrosis Trial in Worldwide (Pomalidomide, Prednisone, Placebo

Completed
Has Results
  • Myelofibrosis With Myeloid Metaplasia
  • +2 more
  • Los Angeles, California
  • +10 more
Nov 7, 2019

Research Tissue Bank

Completed
  • Myelofibrosis
  • +3 more
    • Palo Alto, California
    • +10 more
    Jul 2, 2019

    Myelofibrosis Trial in New York (Panobinostat, Ruxolitinib)

    Completed
    • Myelofibrosis
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Feb 28, 2019

    Patients With Myeloproliferative Disorders

    Completed
    • Myeloproliferative Disease
    • +4 more
      • Scottsdale, Arizona
      • +21 more
      Dec 12, 2018

      Myelofibrosis Trial in Atlanta, New York (Peginterferon alfa-2a)

      Terminated
      Has Results
      • Myelofibrosis
      • Peginterferon alfa-2a
      • Atlanta, Georgia
      • +1 more
      Jun 28, 2018

      Myelofibrosis Trial in Worldwide (Fludarabine, Melphalan +/- ATG)

      Completed
      Has Results
      • Myelofibrosis
      • Fludarabine, Melphalan +/- ATG
      • Chicago, Illinois
      • +11 more
      Apr 7, 2017

      Myelofibrosis Trial in New York (arsenic trioxide, cytarabine)

      Completed
      • Myelofibrosis
      • New York, New York
        Weill Cornell Medical College
      Mar 2, 2017

      Myelofibrosis, Primary Myelofibrosis, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase Trial in New York (mAb to

      Terminated
      Has Results
      • Myelofibrosis
      • +3 more
      • monoclonal antibody to TGF-beta
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Nov 21, 2014

      Myelofibrosis, Essential Thrombocythemia, Polycythemia Vera Trial in United States (CEP-701 (Lestaurtinib))

      Unknown status
      • Myelofibrosis
      • +2 more
      • CEP-701 (Lestaurtinib)
      • Palo Alto, California
      • +6 more
      Nov 24, 2014

      Myelofibrosis Trial in United States (bevacizumab (Avastin))

      Terminated
      Has Results
      • Myelofibrosis
      • bevacizumab (Avastin)
      • Washington, District of Columbia
      • +4 more
      Aug 8, 2014

      Myeloproliferative Disorders, Myelofibrosis, Polycythemia Vera Trial in United States (XL019)

      Terminated
      • Myeloproliferative Disorders
      • +3 more
      • San Francisco, California
      • +4 more
      Apr 4, 2011